青蒿素类药物的生物及抗肿瘤研究进展  

Research Progress on Artemisinin in the Biological and Anti-tumor

作　　者：马艳娇 MA Yanjiao(Jiangxi University of Traditional Chinese Medicine,Jiangxi Province,Nanchang 330000,China)

机构地区：[1]江西中医药大学,江西南昌330000

出　　处：《中国中医药现代远程教育》2021年第24期192-196,共5页Chinese Medicine Modern Distance Education of China

基　　金：江西省中医药管理局科技计划项目【No.2020B0354】;江西中医药大学博士启动基金【No.5151500704】。

摘　　要：青蒿素是通过一系列的化学手段从中草药中提取出来,具有较高医疗价值,它对于疟疾的治疗有很大的帮助。青蒿素在其他层面的运用将会愈发广泛,这主要体现在癌症的治疗、其他寄生虫的抵抗等层面,这一药物未来的前景十分广阔。Artemisinin is a valuable pharmaceutical ingredient developed through chemical extraction from Chinese herbal ingredients,and it has achieved world prominence in the treatment of malaria.In view of the world health organization has begun to pay attention to the seriousness of the malaria parasite resistance to artemisinin drugs in other areas of clinical application development is particularly important:including anti-tumor,prevention and treatment progress in aspects of parasitic resistance,will bring new ideas for its future development prospect.

关 键 词：青蒿素 生物 疟疾 肿瘤 综述 

分 类 号：R285[医药卫生—中药学]